(Q41863750)

13 October 2017

When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis (English)

1 reference

gastrointestinal stromal tumor

13 October 2017

1 reference

Chee Khoon Lee

1

0 references

author name string

Alison Hadley

2

1 reference

13 October 2017

Keshani Desilva

3

1 reference

13 October 2017

Gareth Smith

4

1 reference

13 October 2017

David Goldstein

5

1 reference

13 October 2017

language of work or name

1 reference

21 January 2009

1 reference

World Journal of Surgical Oncology

13 October 2017

1 reference

13 October 2017

7

1 reference

13 October 2017

8

1 reference

Creative Commons Attribution 2.0 Generic

13 October 2017

start time

21 January 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Transforming growth factor beta (TGFbeta) and keloid disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2633001

Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2633001

Keloid pathogenesis and treatment

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2633001

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2633001

beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2633001

Morphological and immunochemical differences between keloid and hypertrophic scar

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2633001

Expression of Transforming Growth Factor β1 in Patients With and Without Previous Abdominal Surgery

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2633001

Response of extraabdominal desmoid tumors to therapy with imatinib mesylate

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2633001

Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall: a clinically important differential diagnosis

18 August 2018

1 reference

12 December 2020

Histopathological differential diagnosis of keloid and hypertrophic scar

1 reference

12 December 2020

Desmoid fibromatosis is a clonal process

1 reference

12 December 2020

Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumors

1 reference

12 December 2020

CD34 immunoexpression in stromal tumours of the gastrointestinal tract and in mesenteric fibromatoses

1 reference

12 December 2020

Identifiers

DOI

10.1186/1477-7819-7-8

1 reference

Dimensions Publication ID

13 October 2017

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1477-7819-7-8

1 reference

13 October 2017

PubMed publication ID

19159438

1 reference